To investigate the role of LDHC tumor expression in regulating T cell function, we generated breast cancer cell models with varying levels of LDHC expression by knocking down LDHC in two basal-like cell lines (MDA-MB-468, BT-549) and one Her2-enriched cell line (HCC-1954). This evidence concerns the gene ERBB2 and breast cancer.